GC-Rise Pharmaceutical's Series B Round

GC-Rise Pharmaceutical raised a round of funding on September 02, 2014. Investors include OrbiMed Advisors.

GC-Rise Pharmaceutical is a pharmaceutical company that aims to bring Western natural medicine with proven clinical benefits to China. The company received approval for Remifemin for natural treatment…

Articles about GC-Rise Pharmaceutical's Series B Round: